# Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation

> **NCT06426758** · — · NOT_YET_RECRUITING · sponsor: **Xiao-Ming Mao** · enrollment: 300 (estimated)

## Conditions studied

- Graves Disease
- Graves' Disease in Remission
- Epstein-Barr Virus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06426758
- **Lead sponsor:** Xiao-Ming Mao
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-05-30
- **Primary completion:** 2026-09-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06426758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06426758, "Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06426758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*